期刊文献+

氧氟沙星PLGA微囊的制备、表征和影响包封率的因素 被引量:5

Ofloxacin-loaded PLGA Microcapsules:Preparation,Characterization and the Factors Affecting Loading Efficiency
下载PDF
导出
摘要 氧氟沙星在眼科临床广泛应用,本研究以氧氟沙星作为模型药物,采用水/油/水(w/o/w)的复乳化和溶剂扩散技术制备氧氟沙星聚乳酸-聚乙醇酸(PLGA)微囊,对影响包封率的工艺参数如药物浓度、PLGA使用量、初乳复乳的搅拌速率进行研究,并对微囊的粒径、表面电位和表面形态的理化性能进行了表征。测试结果表明,根据优化工艺制备的氧氟沙星PLGA微囊的平均粒径511.9±14.6nm,zeta电位-17.97±0.80mV,包封率54.2%,载药量1.94%。包封率随PLGA使用量、初乳搅拌速率的增加而上升,随内水相药物体积和浓度的增加而下降。通过优化的水/油/水(w/o/w)复乳化和溶剂扩散技术制备氧氟沙星PLGA载药微囊的粒度分布窄,载药量和包封率适中,具有较好的临床应用前景。 PLGA microcapsules entrapping Ofloxacin as a model drug, which is widely used in Ophthalmic clinic, were prepared by a w/o/w double emulsification solvent diffusion method. The influence of formulation parameters such as the concentration and volume of the drug, amount of the polymer, stirring rate of primary and secondary emulsions were evaluated. The microcapsule size, zeta potential and morphological study were determined. The results show that the PLGA mierocapsules entrapping Ofloxacin based on the optimized parameters have the mean diameter 511.9±14.6nm, the mean zeta potential-17. 97 ±0. 80mV, the encapsulation efficiency 54. 2% and drug content 1. 94%. The encapsulation efficiency increased with the amounts of PLGA and the stirring rate of primary emulsion, while decreased with drug volumn and concentration. Prepared by an optimized w/o/w double emulsification solvent diffusion method, the Ofloxacin-loaded PLGA mierocapsules may have a better clinical application prospect in future for its narrow distribution, moderate drug content and encapsulation efficiency.
出处 《材料科学与工程学报》 CAS CSCD 北大核心 2009年第2期282-287,共6页 Journal of Materials Science and Engineering
关键词 聚乳酸-聚乙醇酸 氧氟沙星 微胶囊 包封率 PLGA ofloxacin microeapsule encapsulation efficiency
  • 相关文献

参考文献10

  • 1K. Dillen, et al. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles[J]. International Journal of Pharmaeeuties, 2004, 275: 171-187.
  • 2K. Dillen, et al. Evaluation of ciprofloxacin-loaded Eudragit? RS100 or RL100/PLGA nanoparticles [J]. International Journal of Pharmaceutics, 2006, 314 : 72-82.
  • 3E. Gavini, et al. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray- drying as the preparation method: in vitro/in vivo studies [J]. European Journal of Pharmaceutics and Biopharmaceutics, 2004, 57 : 207-212.
  • 4M. Teixeira, et al. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3- methoxyxanthone [J]. European Journal of Pharmaceutics and Biopharmaceutics, 2005, 59 : 491-500.
  • 5F. Ito, et al. Factors affecting the loading efficiency of watersoluble drugs in PLGA microspheres [J]. Colloids and Surfaces B: Biointerfaces, 2008, 61:25-29.
  • 6V. Saxena, et al. Indocyanine green-loaded biodegradable particles: preparation, physicochemical characterization and in vitro release [J]. International Journal of Pharmaceutics, 2004, 278:293-301.
  • 7M.D. Blanco, M. J. Alonso. Development and characterization of protein loaded poly (lactide-co-glycolide) nanospheres[J]. Eur. J. Pharm. Biopharm, 1997, 43:287 -294.
  • 8T. Govender, S. Stolnik, M.C. Garnett, L. Illum, S. Davis. PLGA nanopartieles prepared by nanoprecipitation drug loading and release studies of a water soluble drug [J]. J. Control Release, 1999, 57:171-185.
  • 9Y. N. Konan, et al. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl) porphyrinloaded nanoparticles for photodynamic therapy European [J]. Journal of Pharmaceutics and Biopharmaceutics, 2003, 55:115-124.
  • 10陆彬.药物新剂型与新技术[M].北京:人民卫生出版社,2002.212.

共引文献47

同被引文献47

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部